CLOSEOUT LETTER
Hartley Medical Center Pharmacy, Incorporated MARCS-CMS 483574 —
- Recipient:
- Hartley Medical Center Pharmacy, Incorporated
United States
- Issuing Office:
United States
|
|
Division of Pharmaceutical Quality Operations IV |
|
|
VIA UNITED PARCEL SERVICE
September 26, 2017
William Stuart, Owner/President
Hartley Medical Center Pharmacy, Inc.
113 W. Victoria Street
Long Beach, CA 90805-2162
Dear Mr. Stuart:
The U.S. Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our warning letter [WL #29-16] dated April 21, 2016. Based on our evaluation, it appears that you have adequately addressed the violations contained in this warning letter.
You are expected to take all necessary steps to assure compliance with the Federal Food, Drug, and Cosmetic Act and FDA’s implementing regulations. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Acting for CDR Steven E. Porter, Jr.
Director, Division of Pharmaceutical Quality Operations IV